The page is the record's research on the issuer — no analyst, no rating, no view.

# CervoMed Inc. (NASDAQ: CRVO) — research page

As of 2026-11-08 · us-cm-kg · record version 1

## Identity and listing

The issuer is CervoMed Inc., listed on NASDAQ under ticker CRVO, with ISIN US15713L1098. Its LEI is not on the record: there is no GLEIF record with the exact legal name in jurisdiction US-DE. Its security type is Corporate, its sector is 2834 Pharmaceutical Preparations, and its jurisdiction is United States, Delaware. Its segment is not on the record. Its listing status is listed, not halted.

## The disclosure read

The record holds 78 filings in the twelve months from 2025-11-08 to 2026-11-08, across 43 filing days. The median gap between filing days is 4.0 days. The latest filing is dated 2026-11-06, two days before the record date, and is of type results. The filings by type are 2 agm_egm, 22 corporate_news, 30 directors_dealings, 3 prospectus, 13 regulatory_filing and 8 results. The NASDAQ median is 52 filings, a median cadence gap of 6.0 days and a median latency of 5.0 days across 4,359 issuers. The sector median is 63.0 filings, a median cadence gap of 6.0 days and a median latency of 4.0 days across 526 issuers.

## Auditor

The auditor of record is RSM US LLP, located in Boston, Massachusetts. The record holds no auditor changes.

## Events and halts

The record holds no listing, delisting or name change lines. The domicile change is not on the record: EDGAR states no dated change of state of incorporation on a filing line. The segment move is not on the record, because the exchanges' tier transfers are not EDGAR filings. The halt flag reads listed, not halted.

## Orderability

The outcome is not determinable. The chapter's orderability section carries no client categories, so the outcome cannot name its client category. The rule version is acm-68000/us/reasonable-basis-suitability-finra-rule-2111/r1, and the chapter is as of 2026-11-04.

## Coverage

No research houses were found on the issuer's own investor-relations page. The count is 0.

## Open research

No openly published research notes were found. The count is 0.

## Licensed

Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.

## As-of depth

The issuer's years sealed are 2021, 2022, 2023, 2024, 2025 and 2026. The market's earliest sealed date is 2021-01-04. The live record began on 2026-09-12.

## Sources

8 source pages are named on this page; every value above carries its own source page and read date in the numbers.

- https://www.sec.gov/files/company_tickers_exchange.json (identity.exchange)
- https://www.sec.gov/data-research/sec-markets-data/fails-deliver-data (identity.isin)
- https://data.sec.gov/submissions/CIK0001053691.json (identity.jurisdiction)
- https://mcp.us-cm-kg.ai/events/NASDAQ/CRVO (the disclosure lines)
- https://www.nasdaqtrader.com/rss.aspx?feed=tradehalts (the halt flag)
- https://www.sec.gov/Archives/edgar/data/1053691/000143774926008259/crvo20251231_10k.htm (the auditor)
- https://mcp.us-cm-kg.ai/book/aio.json (the orderability chapter)
- https://mcp.us-cm-kg.ai/record/NASDAQ/CRVO (the record)

---
Allooloo Technologies Corp. · https://getresearch.ai/us/NASDAQ/CRVO · public-record only · the same page signed and receipted: get_research at https://mcp.getresearch.ai/mcp
